The US Food and Drug Administration (FDA) has granted accelerated approval to Jazz Pharmaceuticals’ Modeyso (dordaviprone) as ...

Empathy is a core capability, regardless of function – our ability to connect with others and understand how information is ...

AbbVie and Genmab’s epcoritamab has shown promise as part of a combination treatment for relapsed or refractory follicular ...

With the changes at NHS England and the publishing of the 10-Year Plan, there is a lot of talk of change in the NHS in ...

This year’s ASCO® meeting spotlighted a bold shift in oncology: the possibility of curing metastatic disease. A new trial ...

ASCO® 2025 wasn’t only about oncology breakthroughs - it was also a showcase for how technology is redefining congress ...

In a crowded oncology market, strategy-led storytelling, analytics-driven design, and sustainability-centered innovation are ...

Botanical drugs are stepping into the space between traditional remedies and modern pharmaceuticals. These are not ...

Johnson & Johnson (J&J) has announced that it is seeking US Food and Drug Administration (FDA) approval to include new ...

Proactive protection This trend captures a universal human truth – when the world feels uncertain, we cling to what we can ...

The US Food and Drug Administration (FDA) has approved Apellis Pharmaceuticals’ Sobi-partnered Empaveli (pegcetacoplan) to ...

Bristol Myers Squibb (BMS) has announced that its CD19-directed CAR T cell therapy Breyanzi (lisocabtagene maraleucel) has ...